Discover 3,095 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,095
Featured
Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
for
Endometriosis
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: Female
Age: 21+
Code: NCT06477406
Phase2, Recruiting
Active & Responsive
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
for
Bipolar Disorder
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: All
Age: 18 - 65
Code: NCT05457465
Phase2, Recruiting
Active & Responsive
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
for
Alzheimer Disease, Anxiety, Agitation,Psychomotor
Location: Belmont MA
Sponsor: Mclean Hospital
Sex: All
Age: 55 - 70+
Code: NCT04075435
Early_phase1, Recruiting
Active & Responsive
PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product
for
Chronic Pain
Location: Belmont MA
Sponsor: Staci Gruber, Ph.D.
Sex: All
Age: 21+
Code: NCT03984565
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Providence RI, Boston MA, North Massapequa NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FeaturedActive & Responsive
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, New Haven CT, The Bronx NY, Philadelphia PA,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06619587
Phase1, Recruiting
FeaturedActive & Responsive
Study of an Oral Fluid Testing Approach
for
Cannabis Use, Cannabis Intoxication, Cannabis Use Disorder
Location: Boston MA
Sponsor: Boston Children's Hospital
Sex: All
Age: 18 - 30
Code: NCT06891235
Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Worcester MA, Boston MA, Hartford CT, Westbury NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase3, Recruiting
Featured
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: North Worcester MA, Providence RI, Lebanon NH,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Location: Framingham MA, Burlington MA, East Greenwich RI,
Sponsor: 89bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06419374
Phase3, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
for
Obesity or Overweight
Location: Needham MA, Boston MA, New Haven CT, West Chester PA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351045
Phase3, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Waltham MA, New York NY, Morristown NJ, London,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT05995353
Phase3, Recruiting
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: Newton MA, Boston MA, Watertown MA, Providence RI,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase3, Recruiting
Featured
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for
Alzheimers Disease
Location: Newton MA, Boston MA, Providence RI, The Bronx NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07169578
Phase3, Recruiting
Featured
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for
Alzheimers Disease
Location: Boston MA, Watertown MA, New Haven CT, Springfield NJ,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07170150
Phase3, Recruiting
Featured
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
for
Alzheimer's Disease
Location: Watertown MA, Lady Lake FL, Winter Park FL, Cordova TN,
Sponsor: AbbVie
Sex: All
Age: 50 - 70+
Code: NCT07599670
Phase1, Phase2, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
for
Mature B-Cell Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Baltimore MD, Cincinnati OH,